Cargando…
Pallidal Structural Changes Related to Levodopa-induced Dyskinesia in Parkinson's Disease
BACKGROUND: Despite the clinical impact of levodopa-induced dyskinesia (LID) in Parkinson's disease (PD), the mechanism, especially the role of basal ganglia (BG), is not fully elucidated yet. We investigated the BG structural changes related to LID in PD using a surface-based shape analysis te...
Autores principales: | Youn, Jinyoung, Kim, Mansu, Park, Suyeon, Kim, Ji Sun, Park, Hyunjin, Cho, Jin Whan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120819/ https://www.ncbi.nlm.nih.gov/pubmed/35601615 http://dx.doi.org/10.3389/fnagi.2022.781883 |
Ejemplares similares
-
Serum zinc deficiency is a potential risk factor for the occurrence of levodopa-induced dyskinesia in drug-naïve Parkinson’s disease
por: Kim, Joung Eun, et al.
Publicado: (2023) -
Histological Correlates of Neuroanatomical Changes in a Rat Model of Levodopa-Induced Dyskinesia Based on Voxel-Based Morphometry
por: Zhang, Xiaoqian, et al.
Publicado: (2021) -
“Cueing” for Levodopa-Induced Dyskinesias in Parkinson’s Disease
por: Schaeffer, Eva, et al.
Publicado: (2016) -
Striatal D(1) Dopamine Neuronal Population Dynamics in a Rat Model of Levodopa-Induced Dyskinesia
por: Gao, Shasha, et al.
Publicado: (2022) -
Pallidal versus subthalamic nucleus deep brain stimulation for levodopa‐induced dyskinesia
por: Fan, Shi‐Ying, et al.
Publicado: (2019)